Skip to main content

Advertisement

Table 3 Adverse Events By Person (AE's)

From: Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study

  Placebo N(%) Chamomile N(%) P-valuea
Any AE 10 (58.8) 6 (35.5) 0.03
   Infections 3 (17.6) 2 (11.8) 1.00
   Headaches 1 (5.9) 1 (5.9) 0.76
   Dizziness 1 (5.9) 0 (0.0) 1.00
   GI Symptoms 4 (23.5) 2 (11.8) 0.66
   Musculoskeletal 2 (11.8) 1 (5.9) 0.76
  1. aBased on Fisher's Exact Test